Form 8-K - Current report:
SEC Accession No. 0000950135-07-003409
Filing Date
2007-05-30
Accepted
2007-05-30 06:06:19
Documents
8
Period of Report
2007-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOGEN IDEC INC. b65628bie8vk.htm 8-K 16776
2 EX-99.1 PRESS RELEASE DATED MAY 29, 2007. b65628biexv99w1.htm EX-99.1 10322
3 EX-99.2 TERM LOAN COMMITMENT LETTER, DATED MAY 29, 2007. b65628biexv99w2.htm EX-99.2 55696
4 EX-99.3 REVOLVING LOAN COMMITMENT LETTER, DATED MAY 29, 2007. b65628biexv99w3.htm EX-99.3 54465
5 GRAPHIC b65628bib6562804.gif GRAPHIC 2660
6 GRAPHIC b65628bib6562802.gif GRAPHIC 1864
7 GRAPHIC b65628bib6562803.gif GRAPHIC 1440
8 GRAPHIC b65628bib6562801.gif GRAPHIC 1754
  Complete submission text file 0000950135-07-003409.txt   150253
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 07885438
SIC: 2836 Biological Products, (No Diagnostic Substances)